Oxidants_NNS
,_,
transcription_NN
factors_NNS
,_,
and_CC
intestinal_JJ
inflammation_NN
._.

It_PRP
is_VBZ
now_RB
well_RB
appreciated_VBN
that_IN
chronic_JJ
gut_NN
inflammation_NN
is_VBZ
characterized_VBN
by_IN
enhanced_VBN
production_NN
of_IN
reactive_JJ
metabolites_NNS
of_IN
oxygen_NN
and_CC
nitrogen_NN
._.

Some_DT
of_IN
these_DT
oxidants_NNS
are_VBP
known_VBN
to_TO
modulate_VB
the_DT
expression_NN
of_IN
a_DT
variety_NN
of_IN
genes_NNS
that_WDT
are_VBP
involved_VBN
in_IN
the_DT
immune_JJ
and_CC
inflammatory_JJ
responses_NNS
._.

For_IN
example_NN
,_,
certain_JJ
oxidants_NNS
are_VBP
known_VBN
to_TO
activate_VB
the_DT
nuclear_JJ
transcription_NN
factor_NN
kappa_NN
B_NN
,_,
which_WDT
regulates_VBZ
the_DT
expression_NN
of_IN
a_DT
variety_NN
of_IN
different_JJ
adhesion_NN
molecules_NNS
,_,
cytokines_NNS
,_,
and_CC
enzymes_NNS
._.

Oxidants_NNS
are_VBP
also_RB
known_VBN
to_TO
activate_VB
another_DT
transcription_NN
factor_NN
,_,
activator_NN
protein-1_NN
._.

This_DT
transcription_NN
factor_NN
is_VBZ
composed_VBN
of_IN
products_NNS
from_IN
the_DT
fos_NN
and_CC
jun_NN
proto-oncogene_NN
family_NN
and_CC
is_VBZ
believed_VBN
to_TO
be_VB
important_JJ
in_IN
regulating_VBG
cell_NN
growth_NN
and_CC
proliferation_NN
._.

Finally_RB
,_,
oxidants_NNS
are_VBP
believed_VBN
to_TO
promote_VB
intestinal_JJ
epithelial_JJ
cell_NN
apoptosis_NN
,_,
and_CC
the_DT
B-cell_NN
lymphoma\/leukemia_NN
-2_CD
gene_NN
product_NN
is_VBZ
believed_VBN
to_TO
inhibit_VB
this_DT
phenomenon_NN
in_IN
an_DT
antioxidant-dependent_JJ
manner_NN
._.

Taken_VBN
together_RB
,_,
these_DT
observations_NNS
suggest_VBP
that_IN
nontoxic_JJ
concentrations_NNS
of_IN
reactive_JJ
metabolites_NNS
of_IN
oxygen_NN
and_CC
nitrogen_NN
play_VBP
an_DT
important_JJ
role_NN
in_IN
regulating_VBG
the_DT
expression_NN
of_IN
genes_NNS
involved_VBN
in_IN
the_DT
inflammatory_JJ
response_NN
and_CC
in_IN
modulating_VBG
apoptosis_NN
._.

